Simrat Randhawa, EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 26,530 shares at $89.72 ($2.4M) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Scheduled sale ($2.4M) by EVP, Head of R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.72 | 5,428 | $487K | 20.3% |
| 2 | $90.72 | 16,943 | $1.5M | 63.9% |
| 3 | $91.37 | 4,159 | $380K | 15.8% |
| Total | $90.62 avg | 26,530 | $2.4M | 100% |
| Filing → |
| DNTH | SELL | 2025-11-14 | $14.8M | — | Filing → |
| DNTH | BUY | 2023-09-25 | $53K | — | Filing → |